Tryptases comprise a family of trypsin-like serine proteases, the peptidase family S1. Tryptases are enzymatically active only as heparin-stabilized tetramers, and they are resistant to all known endogenous proteinase inhibitors.
Several tryptase genes are clustered on chromosome 16p13.3. These genes are characterized by several distinct features. They have a highly conserved 3'-UTR and contain tandem repeat sequences at the 5' flank and 3' UTR which are thought to play a role in regulation of the mRNA stability. These genes have an intron immediately upstream of the initiator Met codon, which separates the site of transcription initiation from protein coding sequence. This feature is characteristic of tryptases but is unusual in other genes. The alleles of this gene exhibit an unusual amount of sequence variation, such that the alleles were once thought to represent two separate genes, beta II and beta III.
Beta tryptases appear to be the main isoenzymes expressed in mast cells and club cells, whereas in basophils, alpha-tryptases predominate.
Tryptases have been implicated as mediators in the pathogenesis of asthma and other allergic and inflammatory disorders.[5] In particular, influenza A virus is activated by TPSB2-mediated proteolytic cleavage in the upper respiratory tract.[6]
Hallgren J, Lindahl S, Pejler G (January 2005). "Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase". Journal of Molecular Biology. 345 (1): 129â139. doi:10.1016/j.jmb.2004.10.029. PMIDÂ 15567416.
Sommerhoff CP, Bode W, Matschiner G, Bergner A, Fritz H (March 2000). "The human mast cell tryptase tetramer: a fascinating riddle solved by structure". Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1477 (1â2): 75â89. doi:10.1016/s0167-4838(99)00265-4. PMIDÂ 10708850.
Guida M, Riedy M, Lee D, Hall J (July 2000). "Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog". Pharmacogenetics. 10 (5): 389â396. doi:10.1097/00008571-200007000-00002. PMIDÂ 10898108.
Blom T, Hellman L (February 1993). "Characterization of a tryptase mRNA expressed in the human basophil cell line KU812". Scandinavian Journal of Immunology. 37 (2): 203â208. doi:10.1111/j.1365-3083.1993.tb01757.x. PMIDÂ 8434231. S2CIDÂ 22041090.
Caughey GH (September 2002). "New developments in the genetics and activation of mast cell proteases". Molecular Immunology. 38 (16â18): 1353â1357. doi:10.1016/S0161-5890(02)00087-1. PMIDÂ 12217407.
Pereira PJ, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H, et al. (March 1998). "Human beta-tryptase is a ring-like tetramer with active sites facing a central pore". Nature. 392 (6673): 306â311. Bibcode:1998Natur.392..306P. doi:10.1038/32703. PMID 9521329. S2CID 4421972.
Wu C, Ma MH, Brown KR, Geisler M, Li L, Tzeng E, et al. (June 2007). "Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening". Proteomics. 7 (11): 1775â1785. doi:10.1002/pmic.200601006. PMID 17474147. S2CID 22474278.